Clinical trials

Development Policy 04-05-2017

African Union EU rep: ‘Africa shouldn’t just be a spectator to global decisions’

The African Unions EU representative, Ajay Bramdeo, told EURACTIV Germany that plans for a Marshall Plan for Africa are fundamentally good but warned that the continent needs to be the focus and that healthcare must be the priority.

Health 03-11-2016

Alzheimer Europe chief: Holistic approach needed to tackle dementia

Alzheimer’s disease and other forms of dementia remain underdiagnosed in most European countries, Jean Georges told EURACTIV.

Health 26-07-2016

Pharma expert: new ‘value added medicines’ offer cheaper, customised treatment

A new breed of drugs, called “value added medicines”, could help patients improve their everyday life while in treatment, without increasing healthcare budgets, Christoph Stoller said in an interview with EURACTIV.com

Ben Goldacre
Health 22-10-2014

Ben Goldacre: Pharma industry has destroyed its own reputation

EXCLUSIVE: The great tragedy for the pharmaceutical industry is that it keeps denying that it lobbies against transparency in clinical trials, says Ben Goldacre.

Health 08-03-2013

Medical director: Women under-represented in clinical tests

The lack of gender balance in clinical tests affects almost all medical sectors, but is particularly relevant in cardiovascular diseases where only 33% of trials participants are women. On International Women's Day, Marco Stramba-Badiale is calling for an update of the EU's Clinical Trials Directive to address this imbalance.

Health 19-07-2012

MEP: New clinical trial rules will boost EU pharma research

The European Commission's proposed regulation on clinical trials will help the European pharma industry to stop research centres from fleeing to Asia and America, says Philippe Juvin, a French centre-right MEP.